The impact of clonal size on the revised international prognostic scoring system (R-IPSS) in myelodysplastic syndromes (MDS) with a single cytogenetic abnormality

MLA

Kebede H. Begna, et al. “The Impact of Clonal Size on the Revised International Prognostic Scoring System (R-IPSS) in Myelodysplastic Syndromes (MDS) with a Single Cytogenetic Abnormality.” Journal of Clinical Oncology, vol. 36, May 2018, p. 7068. EBSCOhost, https://doi.org/10.1200/jco.2018.36.15_suppl.7068.

APA

Kebede H. Begna, Mark R. Litzow, Mrinal M. Patnaik, William J. Hogan, Hassan B. Alkhateeb, Rong He, Phuong L. Nguyen, Aref Al-Kali, Patricia T. Greipp, Omar Alkharabsheh, Naseema Gangat, & Salwa S. Saadeh. (2018). The impact of clonal size on the revised international prognostic scoring system (R-IPSS) in myelodysplastic syndromes (MDS) with a single cytogenetic abnormality. Journal of Clinical Oncology, 36, 7068. https://doi.org/10.1200/jco.2018.36.15_suppl.7068

Chicago

Kebede H. Begna, Mark R. Litzow, Mrinal M. Patnaik, William J. Hogan, Hassan B. Alkhateeb, Rong He, Phuong L. Nguyen, et al. 2018. “The Impact of Clonal Size on the Revised International Prognostic Scoring System (R-IPSS) in Myelodysplastic Syndromes (MDS) with a Single Cytogenetic Abnormality.” Journal of Clinical Oncology 36 (May): 7068. doi:10.1200/jco.2018.36.15_suppl.7068.